Understanding the Surge in Pediatric Inflammatory Bowel Disease: Causes, Symptoms, and Treatments

A new study published in Gastroenterology shows that over 100,000 youth in the United States live with pediatric inflammatory bowel disease (IBD). The research, funded by the CDC and led by experts from the Crohn’s & Colitis Foundation, the University of North Carolina at Chapel Hill, and the University of Pennsylvania, highlights a rising trend in pediatric IBD cases, making the U.S. prevalence among the highest globally.

The study examined commercial insurance claims and Medicaid data from five states: Florida, New York, Pennsylvania, Ohio, and California. Researchers identified cases of IBD using medical diagnoses and prescription records. The results showed a 22% increase in Crohn’s disease and a 29% increase in ulcerative colitis among children since 2009.

Lead investigator Dr. Michael D. Kappelman stated, “Our findings reveal that pediatric IBD affects a significant number of American youth.” This study is important for shaping healthcare policy and directing research focus on pediatric IBD.

Key findings include:

• Approximately 100,429 U.S. youth under 20 live with IBD.
• The prevalence of Crohn’s disease is 71 per 100,000, while ulcerative colitis is 44 per 100,000 among children.
• Higher prevalence rates are seen in White youth and in the Northeast.
• Further research is needed to explore racial and ethnic disparities in IBD.

Dr. Andrés Hurtado-Lorenzo, co-author of the study, emphasized the need for more understanding of these variations to improve care for affected children and adolescents.

The study authors believe further investigation is crucial to grasp the factors behind the demographic and geographic differences in pediatric IBD prevalence.

Reference: Kappelman MD, et al. Prevalence of pediatric inflammatory bowel disease in the United States: Pooled estimates from three administrative claims data sources. Gastroenterology. 2024. doi: 10.1053/j.gastro.2024.11.004